Àrgentil Capital Management Limited has announced an equity investment in Sygen Pharmaceuticals Limited. The investment was structured via the sponsor’s investment vehicle Consumer Growth Partners along with other co-investors.

Sygen is an indigenous pharmaceutical company incorporated in 2019 to acquire the key operating assets of Nigerian German Chemicals (NGC). Prior to its acquisition, NGC remained a well-known brand in Nigeria with operations spanning over 50 years.

...